Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Artificial Intelligence In Cardiology Market Value Expansion And Long-Term Growth Outlook
The market for artificial intelligence in cardiology has seen exponential growth in recent years, expanding from $2.72 billion in 2025 to $3.82 billion in 2026, representing a compound annual growth rate (CAGR) of 40.7%. This historic period expansion has been driven by the increasing prevalence of cardiovascular diseases, the early uptake of cardiac imaging software, the rising popularity of wearable medical devices, the need for quicker diagnostic processes, and the broadening of digital healthcare infrastructure.
The artificial intelligence in cardiology market is set to experience remarkable expansion over the coming years, with projections indicating it will reach $15.19 billion by 2030, reflecting a compound annual growth rate (CAGR) of 41.2%. This anticipated surge is fueled by the increasing adoption of remote patient monitoring, the rise of AI-driven clinical decision support tools, the advancement of personalized cardiology therapies, the seamless integration of telecardiology platforms, and a heightened emphasis on preventive cardiac care. Key developments shaping the future include AI-enhanced cardiac imaging analysis, the emergence of predictive analytics for cardiology, the incorporation of wearable heart monitoring devices, automated detection of arrhythmias, and the broadening of remote cardiac care services.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12686&type=smp
Artificial Intelligence In Cardiology Market Growth Factors Supporting Long-Term Expansion
The rising prevalence of cardiovascular conditions is anticipated to drive the expansion of artificial intelligence within the cardiology market moving forward. Cardiovascular diseases encompass any disorders affecting the heart and blood vessels. In the field of cardiology, artificial intelligence is utilized to identify such diseases by assisting in the interpretation of electrocardiograms (ECGs) and spotting conditions including long QT syndrome and atrial fibrillation. Moreover, AI is capable of analyzing extensive datasets gathered from electronic health records, mobile health technologies, and imaging sources. For example, in August 2025, the American Cancer Society—a US-based nonprofit organization—reported a 90.0% increase in the prevalence of cardiovascular disease between 2025 and 2050. Additionally, in October 2024, the Centres for Disease Control and Prevention (CDC), a US federal health agency, stated that 919,032 deaths from cardiovascular disease occurred in the United States in 2023, representing 1 out of every 3 fatalities. Consequently, the significant burden of cardiovascular conditions is fueling the growth of artificial intelligence (AI) in cardiology.
Artificial Intelligence In Cardiology Market Segment Analysis Highlighting Growth Areas
The artificial intelligence in cardiology market covered in this report is segmented –
1) By Component: Hardware, Software Solutions, Services
2) By Application: Cardiac Arrhythmia, Stroke, Ischemic Heart Disease Or Coronary Artery Disease (CAD), Other Applications
3) By End-Use: Lifescience Companies, Healthcare Payers, Healthcare Providers
Subsegments:
1) By Hardware: Imaging Devices, Wearable Devices, Diagnostic Equipment
2) By Software Solutions: Cardiac Imaging Analysis Software, Predictive Analytics Tools, Patient Management Systems, Telemedicine Platforms
3) By Services: Consulting Services, Integration And Implementation Services, Maintenance And Support Services, Training And Education Services
Artificial Intelligence In Cardiology Market Industry Trends Shaping Future Revenue Growth
Leading players in the artificial intelligence cardiology market are emphasizing strategic alliances to transform heart research. Strategic partnerships involve companies drawing on each other’s capabilities and assets to accomplish shared advantages and success. As an example, in October 2023, the Icahn School of Medicine at Mount Sinai, a medical institution based in the United States, revealed its partnership with the Chiba Institute of Technology (CIT), a private university located in Japan. This collaboration between the two academic institutions aims to enhance understanding, prevention, and treatment of cardiovascular diseases, along with developing innovative approaches to address this worldwide health issue. Through this joint effort, Mount Sinai and CIT will work together to conduct international clinical trials that incorporate artificial intelligence into fields such as interventional cardiology, heart failure management, cardiac electrophysiology, cardiac imaging, and preventive cardiology. Furthermore, the research intends to reduce biases related to gender and race at the intersection of AI and cardiovascular studies, ultimately aiming to enhance patient care and outcomes.
Artificial Intelligence In Cardiology Market Leading Companies: Who Holds Significant Market Presence?
Major companies operating in the artificial intelligence in cardiology market are Microsoft Corporation; International Business Machines Corporation; Siemens Healthineers; Koninklijke Philips; Ultromics Ltd; Bay Labs; Cleerly Inc.; RSIP Vision Ltd.; Idoven; Cardiologs Technologies Inc.; Viz.ai; Aidoc; Arterys Inc.; Zebra Medical Vision; AliveCor; DiA Imaging Analysis; Eko Health Inc.; Cardiomatics; UltraSight; Anumana Inc.; CardiAI Inc.; Caption Health Inc.; HeartFlow Inc.; iRhythm Technologies Inc.; Biofourmis Inc.
Access The Complete Artificial Intelligence In Cardiology Market Report:
Artificial Intelligence In Cardiology Market Regional Analysis: Which Region Leads By Revenue?
North America was the largest region in the artificial intelligence in cardiology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in cardiology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Customized Artificial Intelligence In Cardiology Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=12686&type=smp
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.